The FDA wants Amgen's Tavneos off the market. European regulators are investigating data-integrity concerns. And now, a pharma selling the drug in Japan is warning doctors against writing more prescriptions.

The FDA wants Amgen's Tavneos off the market. European regulators are investigating data-integrity concerns. And now, a pharma selling the drug in Japan is warning doctors against…

Swissmedic closely monitoring international developments around the drug Tavneos.